Market Place
Sourcing Support
All News #Library
Rare Diseases
Roche’s Enspryng cuts relapse risk by 68% in Neuroinflammatory
22 Apr 2026 //
PRESS RELEASE
Genentech Drug Fails Rare Disease Trial, Raises Obesity Risk
20 Mar 2026 //
FIERCE BIOTECH
Lupus Research Alliance Cheers FDA Approval Of Gazyva For Lupus
20 Oct 2025 //
PR NEWSWIRE
Genentech, Blueprint tout full approval for Gavreto in rare type of lung cancer
10 Aug 2023 //
ENDPTS
FDA Approves Actemra for SJIA - Rare Form of Juvenile Arthritis
14 Sep 2018 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.